LRRK2 and Parkinson disease: Having shown that daf-16 RNAi could prevent the beneficial effect of daf-2 mutation on lifespan, we next sought to determine if daf-16 RNAi would also prevent the amelioration of phenotypic abnormalities observed in LRRK2(G2019S);daf-2 PD mutants.